The US Food and Drug Administration (FDA) has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, ...

Nearly 60 percent of people asked by Houston Community College approve of a rebrand, but HCC trustees tabled any changes ...

Together with dozens of other NC3 Leadership Schools across the country, Patrick & Henry Community College (P&HCC) hosted its ...

The show will run at 2 p.m. (doors open at 1:30 p.m.) and at 7 p.m. (doors open at 6:30 p.m.) on April 19. Tickets are $15 ...

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. Multiple treatment modalities ...

Black Bear Value Partners, an investment management firm, published its first-quarter 2025 investor letter. A copy of the ...

Hopkinsville Community College will be purchasing new professional program equipment and supplies thanks to the single ...

Hopkinsville Community College will celebrate spring commencement on Friday, May 9, in the Thomas L. Riley Lecture Hall.

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) as first-line treatment for adults with unresectable or metastatic HCC.

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver ...

Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate ...

The U.S. Food and Drug Administration has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for ...